Systemic inflammation increases intestinal permeability during experimental human endotoxemia

F Hietbrink, MGH Besselink, W Renooij, MBM de Smet… - Shock, 2009 - journals.lww.com
F Hietbrink, MGH Besselink, W Renooij, MBM de Smet, A Draisma, H van der Hoeven…
Shock, 2009journals.lww.com
Although the gut is often considered the motor of sepsis, the relation between systemic
inflammation and intestinal permeability in humans is not clear. We analyzed intestinal
permeability during experimental endotoxemia in humans. Before and during experimental
endotoxemia (Escherichia coli LPS, 2 ng/kg), using polyethylene glycol (PEG) as a
permeability marker, intestinal permeability was analyzed in 14 healthy subjects. Enterocyte
damage was determined by intestinal fatty acid binding protein. Endotoxemia induced an …
Abstract
Although the gut is often considered the motor of sepsis, the relation between systemic inflammation and intestinal permeability in humans is not clear. We analyzed intestinal permeability during experimental endotoxemia in humans. Before and during experimental endotoxemia (Escherichia coli LPS, 2 ng/kg), using polyethylene glycol (PEG) as a permeability marker, intestinal permeability was analyzed in 14 healthy subjects. Enterocyte damage was determined by intestinal fatty acid binding protein. Endotoxemia induced an inflammatory response. Urinary PEGs 1,500 and 4,000 recovery increased from 38.8±6.3 to 63.1±12.5 and from 0.58±0.31 to 3.11±0.93 mg, respectively (P< 0.05). Intestinal fatty acid binding protein excretion was not affected by endotoxemia. The peak serum IL-10 concentrations correlated with the increase in PEG 1,500 recovery (r= 0.48, P= 0.027). Systemic inflammation results in an increased intestinal permeability. The increase in intestinal permeability is most likely caused by inflammation-induced paracellular permeability, rather than ischemia-mediated enterocyte damage.
Lippincott Williams & Wilkins